605 related articles for article (PubMed ID: 7721636)
21. Phase II feasibility study of high-dose radiotherapy for prostate cancer using proton boost therapy: first clinical trial of proton beam therapy for prostate cancer in Japan.
Nihei K; Ogino T; Ishikura S; Kawashima M; Nishimura H; Arahira S; Onozawa M
Jpn J Clin Oncol; 2005 Dec; 35(12):745-52. PubMed ID: 16314345
[TBL] [Abstract][Full Text] [Related]
22. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer.
Wong WW; Schild SE; Vora SA; Halyard MY
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):24-9. PubMed ID: 15337536
[TBL] [Abstract][Full Text] [Related]
23. Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors.
Martinez A; Gonzalez J; Spencer W; Gustafson G; Kestin L; Kearney D; Vicini FA
J Urol; 2003 Mar; 169(3):974-9; discussion 979-80. PubMed ID: 12576825
[TBL] [Abstract][Full Text] [Related]
24. Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma.
Boskos C; Feuvret L; Noel G; Habrand JL; Pommier P; Alapetite C; Mammar H; Ferrand R; Boisserie G; Mazeron JJ
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):399-406. PubMed ID: 19203844
[TBL] [Abstract][Full Text] [Related]
25. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.
Peeters ST; Heemsbergen WD; van Putten WL; Slot A; Tabak H; Mens JW; Lebesque JV; Koper PC
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1019-34. PubMed ID: 15752881
[TBL] [Abstract][Full Text] [Related]
26. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959
[TBL] [Abstract][Full Text] [Related]
27. Long-term results in three-dimensional conformal radiotherapy of localized prostate cancer at moderate dose (66 Gy).
Goldner G; Wachter S; Wachter-Gerstner N; Dieckmann K; Pötter R
Strahlenther Onkol; 2006 Sep; 182(9):537-42. PubMed ID: 16944376
[TBL] [Abstract][Full Text] [Related]
28. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy.
Cotter SE; Herrup DA; Friedmann A; Macdonald SM; Pieretti RV; Robinson G; Adams J; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1367-73. PubMed ID: 20934266
[TBL] [Abstract][Full Text] [Related]
29. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer.
Kuban DA; Tucker SL; Dong L; Starkschall G; Huang EH; Cheung MR; Lee AK; Pollack A
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):67-74. PubMed ID: 17765406
[TBL] [Abstract][Full Text] [Related]
30. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.
Michalski JM; Winter K; Purdy JA; Perez CA; Ryu JK; Parliament MB; Valicenti RK; Roach M; Sandler HM; Markoe AM; Cox JD
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):735-42. PubMed ID: 14967428
[TBL] [Abstract][Full Text] [Related]
31. Multi-institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities.
Nihei K; Ogino T; Onozawa M; Murayama S; Fuji H; Murakami M; Hishikawa Y
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):390-6. PubMed ID: 20832180
[TBL] [Abstract][Full Text] [Related]
32. Combined proton and photon conformal radiation therapy for locally advanced carcinoma of the prostate: preliminary results of a phase I/II study.
Yonemoto LT; Slater JD; Rossi CJ; Antoine JE; Loredo L; Archambeau JO; Schulte RW; Miller DW; Teichman SL; Slater JM
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):21-9. PubMed ID: 9054873
[TBL] [Abstract][Full Text] [Related]
33. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
34. Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma.
Benk VA; Adams JA; Shipley WU; Urie MM; McManus PL; Efird JT; Willett CG; Goitein M
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):551-7. PubMed ID: 8514551
[TBL] [Abstract][Full Text] [Related]
35. [Options of hypofractionation of proton boost in locally advanced prostate cancer].
Khmelevskiĭ EV; Pan'shin GA; Kancheli IN; Khoroshkov VS
Vopr Onkol; 2012; 58(6):787-94. PubMed ID: 23600305
[TBL] [Abstract][Full Text] [Related]
36. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.
Zietman AL; DeSilvio ML; Slater JD; Rossi CJ; Miller DW; Adams JA; Shipley WU
JAMA; 2005 Sep; 294(10):1233-9. PubMed ID: 16160131
[TBL] [Abstract][Full Text] [Related]
37. Phase II trial of hormonal cytoreduction with megestrol and diethylstilbestrol in conjunction with radiotherapy for carcinoma of the prostate: outcome results of RTOG 83-07.
Pilepich MV; Buzydlowski JW; John MJ; Rubin P; McGowan DG; Marcial VA
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):175-80. PubMed ID: 7721614
[TBL] [Abstract][Full Text] [Related]
38. A systematic overview of radiation therapy effects in prostate cancer.
Nilsson S; Norlén BJ; Widmark A
Acta Oncol; 2004; 43(4):316-81. PubMed ID: 15303499
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial.
Thompson IM; Tangen CM; Paradelo J; Lucia MS; Miller G; Troyer D; Messing E; Forman J; Chin J; Swanson G; Canby-Hagino E; Crawford ED
JAMA; 2006 Nov; 296(19):2329-35. PubMed ID: 17105795
[TBL] [Abstract][Full Text] [Related]
40. Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer.
Mendenhall NP; Li Z; Hoppe BS; Marcus RB; Mendenhall WM; Nichols RC; Morris CG; Williams CR; Costa J; Henderson R
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):213-21. PubMed ID: 21093164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
